ATP5IF1 and carcinoma: In human carcinomas, IF1 is found predominantly dephosphorylated and hence acting as an inhibitor of the ATP synthase18, contributing to metabolic reprogramming of the cells to an enhanced glycolytic phenotype15,16,19.